Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▴
ENLV	Enlivex Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.24B	n/a	63.9%	n/a	$25.48
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
REGN	Regeneron Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.34B	$4.50B	31.4%	14.4%	1.0%	$41.48
KYNB	Kyntra Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$183.45M	n/a	n/a	n/a	$45.37
ALLR	Allarity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$320.0K	-$11.23M	n/m	-114.3%	n/a	n/a
ATXI	Avenue Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40M	-$2.91M	-207.2%	-158.8%	n/a	n/a
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
BHST	Bioharvest Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	$34.51M	-$11.13M	-32.3%	-43.8%	37.0%	n/a
BIOE	Bio Essence Corp Manufacturing · Year ended 2025-12-31 · USD	$1.90M	$896.2K	47.2%	n/a	485.8%	n/a
BYSI	BeyondSpring Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.01M	n/a	n/a	n/a	n/a
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
DMAC	DiaMedica Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$32.77M	n/a	-58.4%	n/a	n/a
EDSA	Edesa Biotech, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$7.19M	n/a	-57.7%	n/a	n/a
ELAB	PMGC Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$590.1K	-$7.75M	n/m	-98.9%	n/a	n/a
ETON	Eton Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$79.95M	-$4.60M	-5.8%	-17.6%	104.9%	n/a
GNPX	Genprex, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$16.23M	n/a	-203.8%	n/a	n/a
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
LRMR	Larimar Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$165.67M	n/a	-212.2%	n/a	n/a
MBRX	Moleculin Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$33.56M	n/a	-223.6%	n/a	n/a
MNPR	Monopar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$0	-$13.72M	n/a	-10.0%	n/a	n/a
NRXP	NRX Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.45M	-$28.62M	n/m	n/a	n/a	n/a
ORKA	Oruka Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.43M	n/a	-22.3%	n/a	n/a

Rows per page: 2550 100